Literature DB >> 3952166

Central nervous system neurotensin and feeding.

M F Hawkins.   

Abstract

A variety of evidence indicates that neurotensin may be involved in the regulation of ingestive behavior. Cerebral ventricular injections of this peptide produced a dose-dependent decrease in the food intake of food-deprived rats. The duration of the aphagia was found to be approximately 90 minutes for the highest dose employed (100 micrograms). The possibility that tolerance might develop to the aphagic effect of neurotensin was investigated. No evidence of tolerance was found after 6 consecutive days of ventricular injection. In addition to ventricular injections, 2 possible central sites of action were examined: the ventromedial nucleus of the hypothalamus and the nucleus accumbens. While microinjections of neurotensin into the nucleus accumbens did not alter food intake, ventromedial hypothalamic administration resulted in a dose-related reduction in food intake. The results are discussed in relation to the possible role of central nervous system neurotensin in the control of feeding.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3952166     DOI: 10.1016/0031-9384(86)90064-8

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  12 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Activation of central neurotensin receptors reinstates cocaine seeking in the rat: modulation by a D1/D5, but not D2/D3, receptor antagonist.

Authors:  Vanessa Lopak; Suzanne Erb
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 3.  Role of central neurotensin in regulating feeding: Implications for the development and treatment of body weight disorders.

Authors:  Laura E Schroeder; Gina M Leinninger
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-12-27       Impact factor: 5.187

4.  The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperature.

Authors:  David Feifel; Joseph Goldenberg; Gilia Melendez; Paul D Shilling
Journal:  Neuropharmacology       Date:  2009-07-09       Impact factor: 5.250

5.  Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity.

Authors:  Darren Opland; Amy Sutton; Hillary Woodworth; Juliette Brown; Raluca Bugescu; Adriana Garcia; Lyndsay Christensen; Christopher Rhodes; Martin Myers; Gina Leinninger
Journal:  Mol Metab       Date:  2013-08-07       Impact factor: 7.422

6.  Lateral Hypothalamic Neurotensin Neurons Orchestrate Dual Weight Loss Behaviors via Distinct Mechanisms.

Authors:  Hillary L Woodworth; Bethany G Beekly; Hannah M Batchelor; Raluca Bugescu; Patricia Perez-Bonilla; Laura E Schroeder; Gina M Leinninger
Journal:  Cell Rep       Date:  2017-12-12       Impact factor: 9.423

Review 7.  To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance.

Authors:  Juliette A Brown; Hillary L Woodworth; Gina M Leinninger
Journal:  Front Syst Neurosci       Date:  2015-02-18

8.  Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation.

Authors:  Amanda L Sharpe; Erika Varela; Michael J Beckstead
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

9.  Diverse roles of neurotensin agonists in the central nervous system.

Authors:  Mona Boules; Zhimin Li; Kristin Smith; Paul Fredrickson; Elliott Richelson
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-22       Impact factor: 5.555

10.  Genome-wide association study reveals genetic architecture of eating behavior in pigs and its implications for humans obesity by comparative mapping.

Authors:  Duy Ngoc Do; Anders Bjerring Strathe; Tage Ostersen; Just Jensen; Thomas Mark; Haja N Kadarmideen
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.